Replies to post #97327 on Biotech Values

[DewDiligence]

Does PFE opening a rare-disease research center indicate that they are adopting a strategy similar to NVS.

Hi, FL. I would submit that everything PFE has been doing for the past few years has been an attempt to steer the company closer to NVS’ business model. Dan Vasella predicted this would eventually happen as long ago as 2003, when PFE acquired Pharmacia.